 | Webcast - Replay
The Medicines Company at Bank of America Merrill Lynch Health Care Conference
05/15/13 at 11:20 a.m. PT |
| Webcast - Replay
Q1 2013 The Medicines Company Earnings Conference Call
04/24/13 at 8:30 a.m. ET |
| Webcast - Replay
The Medicines Company at RBC Capital Markets' Healthcare Conference
02/26/13 at 9:30 a.m. ET |
Corporate Profile
The Medicines Company provides medical solutions to improve health outcomes for patients in acute and intensive care hospitals worldwide. These solutions comprise medicines and knowledge that directly impact the survival and well-being of critically ill patients.
| Stock Quote |
Recent News| Date | Title | | | 05/09/13 | RECOTHROM Becomes the First and Only Topical Thrombin Indicated for Use in Children Greater Than or Equal to One Month of Age| PARSIPPANY, NJ -- (Marketwired) -- 05/09/13 --
The Medicines Company (NASDAQ: MDCO) today announced that the U.S. Food and Drug Administration (FDA) has expanded the indication for RECOTHROM®, Thrombin topical (Recombinant) to include use in pediatric patients, following completion of a post-approval pediatric clinical trial commitment. RECOTHROM is a recombinant topical thrombin now indicated to aid hemostasis whenever oozing blood and minor bleeding from capillaries and small venules is acce... |
|  | | 05/08/13 | The Medicines Company to Participate in Bank of America Merrill Lynch 2013 Health Care Conference| PARSIPPANY, NJ -- (Marketwired) -- 05/08/13 --
The Medicines Company (NASDAQ: MDCO) will present at the Bank of America Merrill Lynch 2013 Health Care Conference on Wednesday, May 15, in a question and answer session from 11:20 to 11:50 am Pacific Time (2:20 to 2:50 pm Eastern Time).
The session will be webcast with a link available at The Medicines Company's website http://www.themedicinescompany.com.
About The Medicines Company
The Medicines Company (NASDAQ: MDCO) provides medi... |
| | | 04/24/13 | The Medicines Company Reports First Quarter 2013 Financial Results| 23% Increase in Net Revenue to $156 Million
PARSIPPANY, NJ -- (Marketwired) -- 04/24/13 --
The Medicines Company (NASDAQ: MDCO), a global biopharmaceutical company focused on saving lives, alleviating suffering and improving the economic efficiency of the world's leading hospitals, today announced first quarter financial results for 2013.
Financial highlights for the first quarter of 2013 were as follows:
Net revenue increased by 23% to $155.8 million for the first quarter of ... |
| | | 04/11/13 | The Medicines Company to Announce First Quarter 2013 Financial Results on Wednesday, April 24, 2013| Conference Call to Be Held at 8:30 a.m. Eastern Time
PARSIPPANY, NJ -- (Marketwired) -- 04/11/13 --
The Medicines Company (NASDAQ: MDCO) has scheduled its quarterly conference call for Wednesday, April 24 at 8:30 a.m. Eastern Time to discuss first quarter 2013 financial results, operational developments, and outlook for 2013.
The conference call will be available via phone and webcast. The dial in information is listed below:
Domestic Dial In: 877 474 9503
International Dial In: ... |
| |
|
|
Upcoming Events| There are currently no events scheduled. |
Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. |
|
